Continuous Glucose Monitoring in Pregnancy: Importance of Analyzing Temporal Profiles to Understand Clinical Outcomes
Authors:
- Eleanor M. ScottESEleanor M. Scott
- Helen R. MurphyHMHelen R. Murphy
- The CONCEPTT Collaborative GroupTGThe CONCEPTT Collaborative Group
Open Access
- 24 March 2020
- journal article
- research article
- Published by American Diabetes Association in Diabetes Care
- Vol. 43 (6) , 1178-1184
Abstract
OBJECTIVE: To determine if temporal glucose profiles differed between 1) women who were randomized to real-time continuous glucose monitoring (RT-CGM) or self-monitored blood glucose (SMBG), 2) women who used insulin pumps or multiple daily insulin injections (MDIs), and 3) women whose infants were born large for gestational age (LGA) or not, by assessing CGM data obtained from the Continuous Glucose Monitoring in Women With Type 1 Diabetes in Pregnancy Trial (CONCEPTT). RESEARCH DESIGN AND METHODS: Standard summary metrics and functional data analysis (FDA) were applied to CGM data from the CONCEPTT trial (RT-CGM, n = 100; SMBG, n = 100) taken at baseline and at 24- and 34-weeks’ gestation. Multivariable regression analysis determined if temporal differences in 24-h glucose profiles occurred between comparators in each of the three groups. RESULTS: FDA revealed that women using RT-CGM had significantly lower glucose (0.4–0.8 mmol/L [7–14 mg/dL]) for 7 h/day (0800 h to 1200 h and 1600 h to 1900 h) compared with those with SMBG. Women using pumps had significantly higher glucose (0.4–0.9 mmol/L [7–16 mg/dL]) for 12 h/day (0300 h to 0600 h, 1300 h to 1800 h, and 2030 h to 0030 h) at 24 weeks with no difference at 34 weeks compared with MDI. Women who had an LGA infant ran a significantly higher glucose by 0.4–0.7 mmol/L (7–13 mg/dL) for 4.5 h/day at baseline, by 0.4–0.9 mmol/L (7–16 mg/dL) for 16 h/day at 24 weeks, and by 0.4–0.7 mmol/L (7–13 mg/dL) for 14 h/day at 34 weeks. CONCLUSIONS: FDA of temporal glucose profiles gives important information about differences in glucose control and its timing, which are undetectable by standard summary metrics. Women using RT-CGM were able to achieve better daytime glucose control, reducing fetal exposure to maternal glucose.Keywords
This publication has 17 references indexed in Scilit:
- International Consensus on Use of Continuous Glucose MonitoringDiabetes Care, 2017
- Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trialThe Lancet, 2017
- CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi-center, multi-national, randomized controlled trial - Study protocolBMC Pregnancy and Childbirth, 2016
- Analysis of Continuous Glucose Monitoring in Pregnant Women With Diabetes: Distinct Temporal Patterns of Glucose Associated With Large-for-Gestational-Age InfantsDiabetes Care, 2015
- Circadian rhythms, insulin action, and glucose homeostasisCurrent Opinion in Clinical Nutrition and Metabolic Care, 2014
- Diurnal Variation in Vascular and Metabolic Function in Diet-Induced ObesityDiabetes, 2013
- Pathophysiology of postprandial hyperglycaemia in women with type 1 diabetes during pregnancyDiabetologia, 2011
- Functional Data Analysis with R and MATLAB2009
- Hyperglycemia and Adverse Pregnancy OutcomesNew England Journal of Medicine, 2008
- Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes mellitusAmerican Journal of Obstetrics and Gynecology, 1999